Renin-Angiotensin System Inhibitors and the COVID-19 Pandemic-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Renin-Angiotensin System Inhibitors and the COVID-19 Pandemic

Published:2023-04-03 Issue:7 Volume:36 Page:360-362
ISSN:0895-7061
Container-title:American Journal of Hypertension
language:en
Short-container-title:

Author:

Muchaili Lweendo¹,Mweene Bislom C¹,Masenga Sepiso K¹²³^ORCID

Affiliation:

1. HAND Research Group, School of Medicine and Health Sciences, Mulungushi University , Livingstone , Zambia

2. School of Public Health, University of Zambia , Lusaka , Zambia

3. Vanderbilt Institute for Global Health, Vanderbilt University Medical Center , Nashville, Tennessee , USA

Funder

Fogarty International Center

National Institutes of Health

Publisher

Oxford University Press (OUP)

Subject

Internal Medicine

Link

https://academic.oup.com/ajh/advance-article-pdf/doi/10.1093/ajh/hpad031/50084086/hpad031.pdf

Reference22 articles.

1. Renin–angiotensin system inhibitors in the COVID-19 pandemic: consequences of antihypertensive drugs;Ruilope;Eur Heart J,2020

2. Angiotensin-converting enzyme inhibitors in hypertension: to use or not to use?;Messerli;J Am Coll Cardiol,2018

3. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension;Chen;Cochrane Database Syst Rev,2018

4. Effects of inhibition of the renin-angiotensin system on hypertension-induced target organ damage: clinical and experimental evidence;Luca;Monaldi Arch Chest Dis,2021

5. Pharmacological interventions into the renin-angiotensin system with ACE inhibitors and angiotensin II receptor antagonists: effects beyond blood pressure lowering;Düsing;Ther Adv Cardiovasc Dis,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP